Method Article
Roux-en-Y gastric bypass (RYGB) is performed to treat obesity and diabetes. However, the mechanisms underlying RYGB's efficacy are not fully understood, and studies are limited by technical difficulty leading to high mortality in animal models. This article provides instructions on how to perform RYGB in rats with high success rates.
Roux-en-Y gastric bypass (RYGB) is commonly performed for the treatment of severe obesity and type 2 diabetes. However, the mechanism of weight loss and metabolic changes are not well understood. Multiple factors are thought to play a role, including reduced caloric intake, decreased nutrient absorption, increased satiety, the release of satiety-promoting hormones, shifts in bile acid metabolism, and alterations in the gut microbiota.
The rat RYGB model presents an ideal framework to study these mechanisms. Prior work on mouse models have had high mortality rates, ranging from 17 to 52%, limiting their adoption. Rat models demonstrate more physiologic reserve to surgical stimulus and are technically easier to adopt as they allow for the use of surgical staplers. One challenge with surgical staplers, however, is that they often leave a large gastric pouch which is not representative of RYGB in humans.
In this protocol, we present a RYGB protocol in rats that result in a small gastric pouch using surgical staplers. Utilizing two stapler fires which remove the forestomach of the rat, we obtain a smaller gastric pouch similar to that following a typical human RYGB. Surgical stapling also results in better hemostasis than sharp division. Additionally, the forestomach of the rat does not contain any glands and its removal should not alter the physiology of RYGB.
Weight loss and metabolic changes in the RYGB cohort were significant compared to the sham cohort, with significantly lower glucose tolerance at 14 weeks. Furthermore, this protocol has an excellent survival of 88.9% after RYGB. The skills described in this protocol can be acquired without previous microsurgical experience. Once mastered, this procedure will provide a reproducible tool for studying the mechanisms and effects of RYGB.
Obesity and type 2 diabetes have become worldwide epidemics1. Although medical weight loss can improve diabetes in patients, those with severe diabetes benefit most from bariatric surgery. Bariatric surgery has proven to be safe and effective at weight loss and improving or curing type 2 diabetes2,3, even in those with long-standing disease4. Metabolic bariatric procedures, such as the current gold-standard Roux-en-Y gastric bypass (RYGB) surgery, induce rapid and sustained improvements in glucose homeostasis while also reducing the need for diabetic medications5,6,7.
After RYGB, glucose homeostasis improvement occurs rapidly and is independent of the weight loss8. Two major theories have been proposed to explain the metabolic changes associated with diabetes remission that occur following metabolic surgery. First, the hindgut hypothesis postulates that, after bypass, higher concentrations of undigested nutrients reach the distal intestine enhancing the release of hormones such as GLP-1. On the other hand, the foregut hypothesis suggests that bypassing the proximal intestine reduces the secretion of anti-incretin hormones. Both of these effects could lead to early improvement of glucose metabolism9.
Animal models have the potential to be a powerful tool to study these mechanisms. However, a major barrier in utilizing mouse or rat models is the technical difficulty in performing these procedures. Most studies have relied on mouse or rat models10,11,12. Mouse models have been difficult as the mouse stomach is too small to use stapler devices11, and mortality rates are unacceptably high, ranging from 17 to 52%13. In rats, some protocols remain technically difficult to perform due to complex ligation of gastric vessels prior to dividing the stomach12,14. Other models divide the stomach using a stapler but leave a large pouch not consistent with the post RYGB human anatomy11. In this model, we provide detailed instructions on how to perform RYGB using linear staplers in a rat model resulting in a gastric pouch more in keeping with that of human anatomy. Overall, this procedure was associated with excellent survival rates and metabolic outcomes.
Animal use protocols were approved by the Health Science Animal Care and Use Committee at the University of Alberta (AUP00003000). See Figure 1 for a diagram demonstrating the RYGB anatomy.
1. Roux-en-Y gastric bypass
2. Sham surgery
NOTE: Sham surgery is performed similar to RYGB, however, no anastomoses are performed.
3. Postoperative care
Animals and housing
36 male Wistar rats were housed in pairs and were fed 60% sterile rodent high-fat diet starting from six weeks of age (Figure 2). At 16 weeks of age, they underwent RYGB or sham surgery. After the first postoperative week, rats were resumed on a high fat diet. Half of the rats were euthanized at 2 weeks post-operative and the other half were euthanized at 14 weeks postoperative.
Mortality
Overall, 33 (91.7%) rats survived to the planned study endpoint. All rats undergoing early euthanasia underwent necropsy by a veterinarian. Two rats were euthanized within 24 hours. One RYGB had aspiration pneumonitis and one sham rat had fascial dehiscence with unsalvageable bowel. Another RYGB rat was euthanized at two weeks due to anastomotic leak from the gastrojejunostomy. Overall, 88.9% of RYGB rats survived to study endpoint.
Body Weight
Rats undergoing RYGB had a lower postoperative weight than sham rats. Figure 3 demonstrates absolute weights for rats postoperatively while Figure 4 demonstrates postoperative percentage weight change which was statistically significant at all timepoints postoperatively. At 14 weeks, rats who had RYGB had a mean percentage weight change of 6.4% while rats with sham surgery had 23.7% (p = 0.0001).
Intraperitoneal glucose tolerance testing
Fasting blood glucose was not significantly different between any of the cohorts. However, the area under the curve was significantly lower in RYGB compared with sham at 13 weeks (18.1 vs 23.8 mmol-h/L, p=0.046, Figure 5) but was the same for RYGB vs sham at 1 week (20.8 vs 23.3 mmol-h/L, p=0.68).
Figure 1: Roux-en-Y gastric bypass anatomy Please click here to view a larger version of this figure.
Figure 2: Preoperative absolute weight on high fat diet; RYGB, Roux-en-Y gastric bypass Please click here to view a larger version of this figure.
Figure 3: Postoperative absolute weight on high-fat diet; RYGB, Roux-en-Y gastric bypass Please click here to view a larger version of this figure.
Figure 4: Postoperative percentage weight change on high-fat diet; RYGB, Roux-en-Y gastric bypass Please click here to view a larger version of this figure.
Figure 5: Intraperitoneal glucose tolerance testing in gastric bypass vs sham at 13 weeks. RYGB, Roux-en-Y gastric bypass Please click here to view a larger version of this figure.
RYGB involves the creation of a small gastric pouch (less than 30 mL), and the creation of a biliopancreatic limb and a Roux limb (Figure 1). In humans, the biliopancreatic limb is typically 30 to 50 cm and transports secretions from the gastric remnant, liver, and pancreas. The Roux limb is typically 75 to 150 cm in length and is the primary channel for ingested food. The common channel is the remaining small bowel distal to where the two limbs join and is where the majority of digestion and absorption occur, as pancreatic enzymes and bile mix with ingested food17.
The mechanism of weight loss in RYGB is multimodal. The small gastric pouch reduces food intake through mechanical restriction. The bypass results in a malabsorptive component as a significant portion of the small intestine is not absorbing calories and nutrients. More recently, studies have demonstrated that gut hormones play a significant role in weight loss after RYGB as well. These are primarily through ghrelin, peptide-YY, cholecystokinin (CCK), and GLP-1 hormone pathways18.
Rat models provide a powerful method to study the mechanisms behind both the weight and metabolic effects of RYGB. In this paper, we present a RYGB protocol that has low mortality with significant weight loss and metabolic effects. Once the operator became familiar with the technique, the procedure took approximately 90 minutes to perform. The protocol can also be modified with longer biliopancreatic and Roux limb lengths to potentially increase weight loss and metabolic effect. Furthermore, it is technically more feasible than other models as it allows the use of surgical staplers to achieve hemostasis and minimize operative time. Models that rely on sharp division of the stomach without stapling often result in higher mortality due to significant blood loss. The technical skills required to perform the procedure were relatively easy to acquire, and learners were able to comfortably perform the procedure after approximately five to ten non-recovery procedures.
One of the critical steps of this protocol is to limit blood loss during mobilization of the stomach. Careful use of thermal cautery combined with suture ligation of vessels is important. It is also important to perform at least half the circumference of the anastomoses in an interrupted manner. This prevents excessive stricturing at the anastomoses. Furthermore, checking for leaks is crucial as these can lead to sepsis and death. Prior to closing the abdomen, it is essential that the left lobe of the liver is placed in its natural, anterior position and that there is no rotation in the bowel or the stomach as this can lead to visceral ischemia.
Postoperative care is vital to this protocol. Raised wire platforms are required during both fasting and postoperative periods as the consumption of solid material leads to anastomotic obstructions. It is vitally important to provide subcutaneous fluid as the rats may not tolerate oral fluids in the immediate postoperative period. The rats should be acclimatized to oral rehydration therapy and liquid diet as rats may avoid new diets due to associations with postoperative pain. This dietary protocol contributes to significant weight loss in the immediate postoperative period in both the RYGB and sham cohorts, and weight recovery in the sham group took about five weeks. However, strict adherence to this postoperative protocol is vital to reduce morbidity and mortality after RYGB. Additionally, frequent examination of the rats using the Rat Grimace Scale is important to detect for morbidity. In our study, one rat developed a late anastomotic leak which was rapidly detected using this scale and allowed for early euthanasia to reduce suffering.
One of the advantages of this method is that it results in a smaller pouch through the use of surgical staplers to reduce gastric bleeding. When we attempted to sharply divide the stomach without staplers, it leads to excessive bleeding and a much higher mortality rate. However, this also leads to the removal of the forestomach, and this may lead to physiologic changes that are different from that of human RYGB. However, the forestomach is unique to rodents and contains no glands, and should not cause any changes to gut hormones.
The most important limitation of this method is that it requires two surgical stapler reloads per rat, which can be costly. However, excellent survival outcomes potentially reduce cost by requiring less rats for a study, resulting in better utilization of husbandry facilities, surgical equipment and research personnel.
Ethicon supplied two 45 mm linear cutting staplers, multiple 3.5 mm stapler reloads, and 6-0 polypropylene sutures. Authors have no other conflicts of interest to declare.
This study was funded by the American Society for Metabolic and Bariatric Surgery Research Award. Ethicon graciously supplied sutures, staplers, and clips. The lead author's doctoral research was funded in by the University of Alberta Clinician Investigator Program and the Alberta Innovates Clinician Fellowship. We would also like to thank Michelle Tran for her medical illustration of the RYGB anatomy.
Name | Company | Catalog Number | Comments |
2-0 Silk Sutures | Ethicon | K533 | |
3-0 Vicryl Sutures | Ethicon | J219H | |
4% Isoflurane | N/A | N/A | |
5% Dextrose and 0.9% Sodium Chloride Solution - 1000 mL | Baxter | 2B1064 | |
50 mL Conical Centrifuge Tubes | Fisher Scientific | 14-432-22 | |
6-0 Prolene Sutures | Ethicon | 8805H | |
Anesthetic Machine | N/A | N/A | |
Animal Hair Shaver | N/A | N/A | |
Betadine Solution | N/A | N/A | |
Castrojievo Needle Holder with lock 14 cm (smooth curved) | World Precision Instruments | 503258 | |
ECHELON FLEX Articulating Endoscopic Linear Cutter | Ethicon | EC45A | |
Economy Tweezers #4 | World Precision Instruments | 501978 | |
ENDOPATH ETS Articulating Linear Cutter 45mm Reloads | Ethicon | 6R45B | |
Far Infrared Warming Pad Controller with warming pad (15.2 cm W x 20.3 cm L), pad temperature probe, and 10 disposable, non-sterile sleeve protectors | Kent Scientific | RT-0515 | |
Large Rat Elizabethan Collar | Kent Scientific | EC404VL-10 | |
Liquid Diet Feeding Tube (150 mL) | Bio-Serv | 9007 | |
Liquid Diet Feeding Tube Holder (short adjustable) | Bio-Serv | 9015 | |
Micro Mosquito Forceps | World Precision Instruments | 500452 | |
Micro Scissors | World Precision Instruments | 503365 | |
Mouse Diet, High Fat Fat Calories (60%), Soft Pellets | Bio-Serv | S3282 | |
No. 11 Blade and Scalpel Handle | N/A | N/A | |
OPMI Vario Surgical Microscope | ZEISS | S88 | |
Raised Floor Grid | Tecniplast | GM500150 Raised Floor Grid | |
Rodent Liquid Diet, Lieber-DeCarli '82, Control, 4 Liters/Bag | Bio-Serv | F1259 | |
Sodium Chloride Irrigation 0.9% Solution - 500 mL | Baxter | JF7633 | |
Sterile Cotton Swabs | N/A | N/A | |
Sterile Drape | N/A | N/A | |
Sterile Towel | N/A | N/A | |
Thermal Cautery Unit | World Precision Instruments | 501293 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone